In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Due out this spring. PC demo now available. Dark forces are drawn to the lands of Terrinoth. Yet somewhere lies a forgotten relic that could turn the tides. Such power cannot fall into the wrong hands ...

SINCE the first edition of this great work was reviewed in these pages (NATURE, vol. iii., pp. 442, 463), it has been repeatedly reprinted without any important change. But the new issue differs, not ...